3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Diabetic Retinopathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsui, T; Nakamura, K; Sato, T; Takeuchi, M; Yamagishi, S | 1 |
1 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Diabetic Retinopathy
Article | Year |
---|---|
Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.
Topics: Acyl Coenzyme A; Diabetic Retinopathy; Glycation End Products, Advanced; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Biological; Vascular Endothelial Growth Factor A | 2006 |